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Penelitian ini memberikan gambaran gangguan psikiatri terutama
gangguan depresi, cemas, dan kesulitan tidur pada pasien nyeri
neuromuskuluskeletal kronis.
Tujuan penelitian ini adalah mengukur prevalensi penyakit komorbiditas
psikiatri pada pasien nyeri neuromuskuloskeletal kronis.
Penelitian ini merupakan penelitian potong lintang dengan metode
pengambilan data konsekutif. Data diambil di klinik rawat jalan
departemen saraf di rumah sakit Atma Jaya, Jakarta, antara bulan Juli-
Desember 2015. Kriteria Diagnostic and Statistical Manual of Mental
Disorder (DSM) V digunakan dalam mendiagnosis gangguan psikiatri.
Didapatkan 55 sampel penelitian, terdiri dari 12 laki-laki (21,8%), 43
perempuan (78,2%). Tiga puluh diantaranya berusia ≥ 60 tahun (55%)
dan 25 lainnya ˂ 60 tahun (45%). Nyeri yang paling sering adalah nyeri
punggung bawah 30 pasien (55%). Nyeri non-neuropatik 12 pasien
(22%), dan nyeri neuropatik 43 pasien (78%). Intensitas nyeri paling
banyak tergolong berat, Visual Analog Scale (VAS) ≥8 (43%). Penyakit
psikiatri tersering adalah gangguan tidur (20%), diikuti gangguan cemas
disertai insomnia (16,3%) dan gangguan cemas (12,7%).
Sebagian besar nyeri kronis disertai komorbiditas gangguan psikiatri,
kondisi ini harus dipertimbangkan dalam evaluasi, diagnosis, dan terapi.
Nyeri kronis sering disertai dengan gangguan psikiatri, sehingga harus
dilakukan evaluasi, diagnosis, dan terapi yang menyeluruh untuk
mencapai fungsi optimal dan kualitas hidup yang baik.
Peneliti menyarankan untuk penelitian selanjutnya untuk
mengumpulkan data dari beberapa rumah sakit dan melakukan penelitian
analitik sehingga mampu menjelaskan hubungan antara faktor-faktor
yang berpengaruh terhadap munculnya penyakit komorbiditas.
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ABSTRACT This study describe comorbid psychiatric disorder especially in depressive
disorder, anxiety disorder and sleep disturbance in chronic
neuromusculoskeletal pain patients.
The aim of this study is to measure the prevalence of psychiatric
comorbidity in choric neuromusculoskeletal pain.
Cross sectional study with consecutive sampling method is used in this
study. The data are collected in the neurology clinic in Atma Jaya
Hospital, Jakarta between July – December 2015. Diagnostic and
Statistical Manual of Mental Disorder (DSM) V criteria was used to
diagnose the psychiatric condition.
The data were obtain from 55 study samples, consist of 12 males (21,8%),
43 females (78,2%). Thirty of them are ≥ 60 years old (55%) and 25 are ˂
60 years old (45%). The most common is low back pain 30 patients
(55%). Non-neuropathic pain 12 patients (22%), and neurophatic pain
43 patients (78%). The most common pain intensity is severe, Visual
Analog Scale (VAS) ≥ 8 (43%). The most common psychiatric disorder is
insomnia (20%), followed by anxiety and insomnia (16,3%), and anxiety
(12,7%).
Majority of chronic pain has psychiatric disoder comorbidity, coexisting
condition should be considered in evaluation, diagnosis, and therapy.
Chronic pain usually accompanied by psychiatric disorder, so thorough
evaluation, diagnosis and therapy have to be fully addressed to achieve
optimum functionality and good quality of life.
Next study should collect samples from some hospitals and design the
analitic study that can explain association between factors that can
influence the comorbidity.
INTRODUCTION
The term comorbidity refers to
the coexistence of an index disease with
another clinical entity (Fishbain et al.,
1998). Comorbidity is important for
some reasons. First, the presence of
comorbid disease with the index can
interfere, complicate or worsen the
treatment. Second, in medical reasearch
especially in statistics, failure to classify
and analyze the comorbid disease may
mislead the medical statistics and may
cause spurious comparisons between
planning and evaluation of patient
treatment. In this study we will assess
the comorbidity of psychiatric disorder
in chronic pain.
The triad of chronic pain, sleep
disturbance, depression/anxiety must
be fully addressed in treating chronic
pain for optimum result. It will be
difficult to restore patient optimum
functionality if we ignored this triad
(Nicholson and Verma, 2004).
It was believed that patient can
control their sensitivity of pain. Who
believed they can resist the pain can do
daily activity and mediate adaptation
with their pain (Jensen et al., 1991).
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In Europe, chonic pain with
moderate to severe pain intensity
occurs in 19% adult population,
seriously affect their daily activity and
quality of life (Breivik et al., 2006). In
America, patient with mayor
depressive disorder (MMD) have
higher proportion of chornic pain than
those without MMD (66% versus 43%)
(Arnow et al., 2006). In Indonesia, study
of psychiatric disorder comorbidity
(depressed mood, anxiety, and sleep
disturbance) in chronic
neuromusculoskeletal pain never been
studied. Meanwhile, the statistic
prevalence of chronic pain remain high.
Multicenter study in Indonesia found
that there is 25% visite of chronic pain
in that month (Meliala, 2003). Based on
previous survey, there is 55% visite of
pain disorder in Neurology outpatient
clinic of Atma Jaya Hospital in 2014.
For this concern, the researchers
curious to find another impact of
chronic pain in patient psychological
function. The aim of this study is to
measure the prevalence of psychiatric
comoridity in chronic
neuromusculoskeletal pain.
METHODS
The method of this study is cross
sectional with consecutive sampling.
The samples were collected in the
outpatient neurology clinic setting in
Atma Jaya Hospital, Jakarta between
July – December 2015. Every patient
was collected based on chief complain
of chronic pain more than 12 weeks.
The neuromusculoskeletal pains
include cervical pain, shoulder or back
pain, extremity pain and etc. (diabetic
neuropathy, central post stroke pain,
fibromyalgia, trigeminal neuralgia).
Headache is excluded in this study.
Visual Analoge Scale (VAS) is used to
assess pain severity. Mild pain (1-4),
moderate pain (5-7), severe pain (≥ 8)
(Boonstra et al., 2014; Hawker et al.,
2011). Psychiatric disorder comorbidity
include depressive mood, anxiety
disorder, and sleep disturbace which
meet the criteria of DSM V.
Inclusion criteria in this study :
1. Patient who come to visite
outpatient neurology clinic in
Atma Jaya Hospital with the chief
complain of chronic pain
2. Patient with chronic
neuromusculoskeletal pain more
than 12 weeks.
Exclusion criteria in this study :
1. Patient who have psychiatric
disorder before chronic
neuromusculoskeletal pain occur.
2. Patient with cancer pain.
The data are shown in table and
pie diagram and processed using SPSS
17.0 program.
RESULTS
Table 1. Percentage of Psychiatric
Disorder Comorbidity
Psychiatric Disorder
Comorbidity
n %
Depression 3 5,4%
Anxiety 7 12,7%
Insomnia 11 20%
Depression and
Anxiety 2 3,6%
Depression and
Insomnia 1 1,8%
Anxiety and Insomnia 9 16,3%
Depression, Anxiety
and  Insomina 5 9%
No Psychiatric
Disorder Comoridity 17 30,9%
Total 55 100%
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The data were obtain from 55
study samples, consist of 12 males
(21,8%), 43 females (78,2%). Thirty of
them are ≥ 60 years old (55%) and 25
are ˂ 60 years old (45%). The most
common is low back pain 30 patients
(55%). Non-neuropathic pain 12
patients (21,8%), and neurophatic pain
43 patients (78,2%). The most common
pain intensity is severe, VAS ≥8 (43%).
The most common psychiatric disorder
is insomnia (20%), followed by anxiety
and insomnia (16,3%), and anxiety
(12,7%).
Fig.1 Frequency of chronic
neuromusculoskeletal pain in this
study (n=55)
Fig.2 Pain intensity distribution
in this study (n=55)
DISCUSSION
The results of this study show
that patient <60 years old suffer chronic
neuromusculoskeletal pain more than
patient ≥60 years old. The most
common chronic neuromusculoskeletal
pain is low back pain. This result agree
with previous study that the most
common pain in general population is
low back pain (Tsang et al., 2008). This
chronic pain has close association with
psychiatric disorder especially anxiety
and depression (Bair et al., 2008;
Dieleman et al., 2008; Tsang et al.,
2008). along with sleep disorder as this
study shown (Mulla et al., 2014). So, in
daily practice in outpatient clinic,
chronic pain must be assessed further,
whether the patient has psyciatric
disorders and consult a psychiatrist if
needed.
Results of this study show that
the most common psychiatric
comoridity in chronic
neuromusculoskleteal pain is sleep
disorder (20%). This result is diffrent
with previous study in Germany which
is the most common psychiatric
comorbidity is depression (Gerrits et
al., 2012).
One of the most common
neuromusculoskeletal pain is
fibromyalgia. The etiology is still
idiopathic and affecting more female
than male. Mood disorder and axiety
disorder can worsen this condition.
Previous fibromyalgia clinical trials
have included clinical assessments to
identify psychiatric disorder and
determine the impact of comorbidity on
treatment respons. The results are
decrese pain severity using
antidepressant and SSRI. Other
treatment on anxiety and sleep disorder
associated with chronic pain is
anticonvulsant (ex. Pregabalin and
5%
13%
55%
27% Cervical pain
Etremity pain
Back pain
Others pain
17%
40%
43% Mild
Moderate
Severe
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Gabapentin) that decrease pain
severity, increase slow-wave sleep and
have some anxiolytics effects (Arnold,
2006).
Some of drugs that used in this
study are anticonvulsants (ex.
Pregabalin and Gabapentin, 52,5%) and
tricyclic antidepressant (TCA) (ex.
Amitriptilin, 7,5%). These drugs also
have therapeutic effect on depression,
anxiety and sleep disorder (Boyle et al.,
2012). Bolyle reported in their
randomized controlled trial, 83 patient
with diabetic neuropathy shown sleep
continuity improvement with
pregabalin (p<0,001), and increased
wake and reduced total sleep time with
duloxetine (p<0,01 and p<0,001).
Despite negative effects on sleep,
duloxetine can stimulate central
nervous system and increase sensory-
motor ability.
One of the fundamental question
“Is there any diffrence in psychiatric
disorder prevalence rate in non-
neuropathic pain and neuropathic
pain?”. Short answer is yes, there is!
Researchers (Ohayon and Stingl, 2012),
reported in 3011 patients shown that
patients with neuropathic pain have
higher pain severity and limitation in
daily activity compare to non-
neuropathic pain. Patients with mayor
depression disorder have 3 times risk
higher to have non-neuropathic pain
and 6 times higher in having
neuropathic pain.
Another question is “Is chronic pain
has another pain and psychiatric
comorbidity ?”. The answers is yes.
Researchers (Gore et al., 2012) studied
in 101.294 patients with chronic low
back pain had a greater comorbidity
burden (p<0,0001) of musculoskeletal
and neuropatic pain conditions and
psychiatric condition  depression,
anxiety and sleep disorder significantly
higher compare to control group (13%
vs 6,1%; 8% vs 3,4%; 10% vs 3,4%
respectively). Others psychiatric
comorbidity are affective disorders,
substance-related disorders, and
personality disorders (Fishbain et al.,
1998).
The diffrences in prevalence rate
and comorbidity in non-neuropathic
pain and neuropathic pain show how
important this condition to be
concerned along with vary modalities
used in pain assessment.
This study has superiority which is
the samples of this study quite many
that collected only in one hospital in 6
months duration, and this study can
describe the most psychiatric disorder
that occur in chronic
neuromusculoskelatal pain patients.
Beside, this study has some inferiority
which are this study is descriptive that
can not explain association between
factors that can influence the
comorbidity and samples collection
only from one hospital.
Researchers suggested that for the
next study to collect samples from some
hospital and the study design is
analytic that can explain association
between factors than can influcene the
comoridity.
CONCLUSIONS
Very high prevalence of choric
pain needs concern about comorbid
disorsder. Chronic pain usually
accompanied by psychiatric disorder,
so thorough evaluation, diagnosis and
therapy have to be fully addressed to
achieve optimum functionality and
good quality of life.
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